Dipivefrin and Epinephrine Treatment of Elevated Intraocular Pressure
- 1 October 1979
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 97 (10) , 1865-1866
- https://doi.org/10.1001/archopht.1979.01020020313004
Abstract
• Every 12 hours 0.1% dipivefrin was administered to one eye and 2% epinephrine hydrochloride was administered to the fellow eye of 42 patients with primary open-angle glaucoma or ocular hypertension in a randomized, double-masked study lasting three months. Dipivefrin produced similar percent reductions in intraocular pressure (18.6%) to epinephrine (21.0%), as well as similar increases in outflow facility and pupil diameter. A significantly lower incidence of burning and stinging after drug instillation was noted with dipivefrin therapy. This study supported the contention that dipivefrin is an effective and safe alternative to epinephrine therapy for the reduction of elevated intraocular pressure.This publication has 4 references indexed in Scilit:
- Clinical Comparison of Dipivalyl Epinephrine and Epinephrine in the Treatment of GlaucomaAmerican Journal of Ophthalmology, 1979
- OCULAR ABSORPTION AND METABOLISM OF TOPICALLY APPLIED EPINEPHRINE AND A DIPIVALYL ESTER OF EPINEPHRINE1978
- The dose-response relationships of dipivalyl epinephrine in open-angle glaucomaAlbrecht von Graefes Archiv für Ophthalmologie, 1978
- Dipivefrin Use in Patients With Intolerance to Topically Applied EpinephrineArchives of Ophthalmology (1950), 1977